Inactive

Esperante BV

General contacts
Investor type

PE

Founded

2005

AUM

-

Location

Hoofddorp, North Holland, Netherlands

Investment Ticket

$50-100 m

Investment Stage

Series A Seed Late Stage (Series C+)

Region of investment

North America Europe
Investor profile last updated: 21 August, 2026

Profile

Esperante BV is a Netherlands-based private equity firm that specializes in strategic investments across various sectors. The firm was founded in 2005, focusing on building a diversified portfolio through substantial investments in companies that show potential for growth and value creation. Esperante operates with a small but dynamic team, comprising seasoned professionals with backgrounds in finance and industry expertise, aiming to offer both capital and strategic partnerships to its portfolio companies.

Esperante BV invests primarily in sectors such as Healthcare Services, Technology, and Industrial. It typically targets investment opportunities in Europe and North America, with a flexible approach to deal size and stages focusing on mature companies seeking growth or restructuring. The firm's total assets under management are not publicly disclosed, and it does craft bespoke investment strategies tailored to the needs of each company in its portfolio.

The firm's notable investments include HealthTech Innovations - a provider of healthcare solutions, and TechPlus - a technology services company. Esperante's investment strategy involves active involvement in portfolio companies, providing both capital and strategic guidance to drive value creation.

Industry

HealthTech Life Sciences Technology MedTech Pharmaceuticals Other Industrial Healthcare Services Biotechnology

Contacts

Name
Title
Email
Social Networks
avatar
Dean Slagel Managing Director
Managing Director
d•••@•••
LinkedIn
avatar
Erik Schropp Director
Director
e•••@•••
LinkedIn
Upgrade to see contacts
avatar
1ZvzeCG8WfhinjpI 1ZvzeCG8WfhinjpI
1ZvzeCG8WfhinjpI
[email protected]
linkedin twitter
avatar
1ZvzeCG8WfhinjpI 1ZvzeCG8WfhinjpI
1ZvzeCG8WfhinjpI
[email protected]
linkedin twitter
avatar
1ZvzeCG8WfhinjpI 1ZvzeCG8WfhinjpI
1ZvzeCG8WfhinjpI
[email protected]
linkedin twitter
Investment-team contacts for Esperante BV — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Esperante BV

Esperante BV is a private equity firm. It backs companies at Series A, Seed and Late Stage (Series C+), writing tickets of $50-100 m.
Esperante BV is located in Hoofddorp, North Holland, Netherlands.
Esperante BV was founded in 2005.
Esperante BV invests in companies and startups in HealthTech, Life Sciences, Technology, MedTech, Pharmaceuticals, Other, Industrial, Healthcare Services, Biotechnology.
Esperante BV invests in companies and startups in North America, Europe.
Esperante BV invests in companies and startups at Series A, Seed, Late Stage (Series C+).
Esperante BV usually invests $50-100 m on average.
Esperante BV can be reached through its website esperanteventures.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Esperante BV — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Esperante BV directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.